Skip to main content
Fig. 5 | Parasites & Vectors

Fig. 5

From: Glabridin exhibits potent inhibitory effects against Toxoplasma gondii in vitro and in vivo

Fig. 5

Glabridin’s effects on the metabolomic profile of Toxoplasma gondii RH tachyzoites. a Partial Least Squares Discriminant Analysis (PLS-DA) illustrating the separation between glabridin-treated and control groups. b Volcano plot of differentially accumulated metabolites (DAMs), with log2 fold change on the X-axis and −log10 (P value) on the Y-axis. The vertical dotted lines indicate a two-fold change threshold; grey dots represent non-significant metabolites, while red and green dots indicate up- and downregulated DAMs, respectively. c Heatmap of DAM clusters, showing metabolic differences between glabridin-treated and untreated T. gondii. Red and blue indicate up- and downregulated metabolites, respectively. The impact factor represents the ratio of DAMs to the total metabolites within each pathway. d KEGG pathway analysis of differential metabolites, where dot color reflects log10 (P value) and dot size corresponds to the number of DAMs enriched in each KEGG pathway

Back to article page